Volatile Week, but Green? Click to watch the new Podcast.

$1.01 (-7.34%)

Volume: 1.581M

Closed: Jul 01, 2022

Hollow Logo Score: -4.768

Atossa Genetics Stock Forecast

BUY SELL NASDAQ:ATOS
$1.01 (-7.34%)

Volume: 1.581M

Closed: Jul 01, 2022

Score Hollow Logo -4.768

Atossa Genetics Inc. Company Profile

2300 Eastlake Avenue East

Seattle WA 98102

206-588-0256

www.atossagenetics.com

Atossa Genetics

Description

Atossa Genetics Inc., a clinical-stage pharmaceutical company, focuses on developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions in the United States. The company is conducting a Phase II clinical study using microcatheters to deliver fulvestrant as a potential treatment of ductal carcinoma in-situ and breast cancer; and a pharmaceutical program under development is Afimoxifene Topical Gel for the treatment and prevention of hyperplasia of the breast. Atossa Genetics Inc. was founded in 2009 and is headquartered in Seattle, Washington.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE